Novanta (NASDAQ:NOVT) Issues FY 2026 Earnings Guidance

Novanta (NASDAQ:NOVT – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 3.660-3.710 for the period, compared to the consensus EPS estimate of 3.690. The company issued revenue guidance of $1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Novanta also updated its Q4 2026 guidance to 0.910-0.960 EPS.

Novanta Stock Performance

NOVT opened at $123.71 on Wednesday. The stock has a market capitalization of $4.68 billion, a price-to-earnings ratio of 94.44 and a beta of 1.71. The company has a fifty day moving average of $141.80 and a 200 day moving average of $142.52. Novanta has a fifty-two week low of $98.27 and a fifty-two week high of $176.38. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.79 and a current ratio of 4.57.

Novanta (NASDAQ:NOVT – Get Free Report) last announced its quarterly earnings results on Monday, November 9th. The technology company reported $1.05 EPS for the quarter, topping the consensus estimate of $0.97 by $0.08. Novanta had a net margin of 4.89% and a return on equity of 10.62%. The business had revenue of $305.01 million for the quarter, compared to analysts’ expectations of $301.02 million. During the same quarter in the previous year, the company earned $0.87 EPS. The business’s quarterly revenue was up 23.1% compared to the same quarter last year. As a group, sell-side analysts forecast that Novanta will post 3.70 earnings per share for the current fiscal year.

Analysts Set New Price Targets

NOVT has been the topic of a number of research analyst reports. Wall Street Zen upgraded Novanta from a “hold” rating to a “buy” rating in a research report on Saturday. Zacks Research cut Novanta from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 6th. Weiss Ratings downgraded Novanta from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Tuesday. Finally, Robert W. Baird set a $194.00 price objective on Novanta in a report on Friday, August 7th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $194.00.

Get Our Latest Stock Report on NOVT

Key Stories Impacting Novanta

Here are the key news stories impacting Novanta this week:

  • Positive Sentiment: Third-quarter revenue rose 23.1% year over year to $305 million, above estimates of about $301 million. Adjusted EPS of $1.05 also topped the $0.97 consensus. Customer bookings increased 29%, backlog reached $543 million, and operating cash flow improved to $39.3 million. Novanta third-quarter results
  • Neutral Sentiment: Management outlined reported growth of more than 15% for 2027, while noting the company is working through a temporary Stockport disruption. The growth outlook is encouraging, though the disruption adds uncertainty. Novanta 2027 outlook
  • Negative Sentiment: Fourth-quarter adjusted EPS guidance of $0.91–$0.96 is below analysts’ $1.02 estimate, even as revenue guidance of $306–$312 million brackets the $308.6 million consensus. Full-year adjusted EPS guidance is $3.66–$3.71. This softer earnings outlook may overshadow the quarterly beat. Novanta Q3 earnings call transcript
  • Negative Sentiment: Despite growth in revenue, GAAP net income fell to $2.0 million from $10.7 million a year earlier; GAAP diluted EPS declined to $0.05 from $0.30. The gap between rising sales and lower reported profit could concern investors. Novanta Q3 financial details

About Novanta

(Get Free Report)

Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software. The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.

See Also

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.